| Megasoft Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532408 |
NSE Symbol : MEGASOFT |
P/E(TTM) : 10.20 |
|
ISIN Demat : INE933B01012 |
Div & Yield% : 0.00 |
EPS(TTM) : 19.56 |
|
Book Value(₹) : 43.59 |
Market Cap(₹Cr) : 1,471.71 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.85 | 187.65 | 12.38 | 12.73 | 8.56 | 7.61 |
| Total Income | 3.85 | 187.65 | 12.38 | 12.73 | 8.56 | 7.61 |
| Total Expenditure | 1.97 | 15.94 | 2.87 | 3.33 | 2.12 | 1.82 |
| PBIDT | 1.88 | 171.71 | 9.52 | 9.40 | 6.44 | 5.79 |
| Interest | 0.14 | 3.42 | 4.87 | 4.64 | 4.49 | 4.22 |
| PBDT | 1.74 | 168.29 | 4.65 | 4.77 | 1.96 | 1.57 |
| Depreciation | 0.93 | 0.85 | 1.21 | 1.17 | 1.05 | 1.04 |
| Tax | 0.00 | 31.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.81 | 136.44 | 3.44 | 3.59 | 0.91 | 0.54 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.81 | 136.44 | 3.44 | 3.59 | 0.91 | 0.54 |
| EPS (Unit Curr.) | 0.11 | 18.49 | 0.47 | 0.49 | 0.12 | 0.07 |
| EPS (Adj) (Unit Curr.) | 0.11 | 18.49 | 0.47 | 0.49 | 0.12 | 0.07 |
| Calculated EPS (Unit Curr.) | 0.11 | 18.49 | 0.47 | 0.49 | 0.12 | 0.07 |
| Calculated EPS (Adj) (Unit Curr.) | 0.11 | 18.49 | 0.47 | 0.49 | 0.12 | 0.07 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.44 | 73.98 | 1.86 | 1.95 | 0.49 | 0.29 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.44 | 73.98 | 1.86 | 1.95 | 0.49 | 0.29 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 73.77 | 73.77 | 73.77 | 73.77 | 73.77 | 73.77 |
| Reserve & Surplus | 275.56 | 274.75 | 110.57 | 107.08 | 103.48 | 102.58 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PATM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |